Stimulating PBMCs from NSCLC patients with RLI showed that it systematically increased the expression of activating receptors NKp30, NKp44, CD107a, and intracellular TNF-α, indicating that RLI could rescue the functionality of NK cells in patients with NSCLC [30]. The gene discussed is NCR3; the disease is non-small cell lung carcinoma.